The Food and Drug Administration chose the same vaccine formulation in 2017 and 2016, in part because
the dominant circulating strain stayed the same.
«The original strain used as a reference for the vaccine was basically a perfect match to
the dominant circulating strain, and the predicted efficacy would have been around 47 percent.
Not exact matches
Although the K13 C580Y
strain is becoming
dominant in parts of the region, the group said in a carefully worded report in March, that is not the case everywhere in the Greater Mekong, where several lineages are
circulating more or less in equilibrium.
That's because multiple
strains circulate every year, and it's difficult for scientists to predict perfectly which
strains will be
dominant.